Adults aged 45 and overmany of whom are beginning to feel the wear and tear of long workdays, sedentary lifestyles, or sports-related injuriesare entering a phase of life where nerve sensitivity, tingling, and radiating back and leg discomfort become more common
Why GLP-1 Weight Loss Plateaus Happen Weight loss plateaus happen for a variety of physiological reasons
Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
The last thing we need to do is dump a lot of expectations on their plate before we give them answers and solutions to their lack of energy
The goal isnt to treat a marker, its to understand why the check-engine light is on in the first place
